Three Arch Management IV, L.L.C.'s Net Worth
$6.27 Million
Who is Three Arch Management IV, L.L.C.?
Three Arch Management IV, L.L.C. has an estimated net worth of $6.27 Million. This is based on reported shares across multiple companies, which include NEVRO CORP, CONCERT PHARMACEUTICALS, INC., ACELRX PHARMACEUTICALS INC, and NORTH AMERICAN SCIENTIFIC INC.
SEC CIK
Three Arch Management IV, L.L.C.'s CIK is 0001365429
Past Insider Trading and Trends
2011 was Three Arch Management IV, L.L.C.'s most active year for acquiring shares with 20 total transactions. Three Arch Management IV, L.L.C.'s most active month to acquire stocks was the month of January. 2015 was Three Arch Management IV, L.L.C.'s most active year for disposing of shares, totalling 36 transactions. Three Arch Management IV, L.L.C.'s most active month to dispose stocks was the month of January. 2011 saw Three Arch Management IV, L.L.C. paying a total of $6,448,950.00 for 4,027,421 shares, this is the most they've acquired in one year. In 2015 Three Arch Management IV, L.L.C. cashed out on 1,236,639 shares for a total of $20,249,312.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEVRO CORP (NVRO) Snapshot price: $17.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +52,962.15% | 2.21M |
—
|
—
| 2.21M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -47.77% | -68.85K |
$19.92 | -$1,378,606.08 | 75.29K |
Dec 14 - Dec 16
| |||
Form 4
| -63.54% | -120.00K |
$18.22 | -$2,186,400.00 | 68.85K |
Sep 10
| |||
Form 4
| -42.99% | -760.00K |
$16.01 | -$12,012,600.00 | 1.01M |
Aug 14 - Aug 18
| |||
Form 4
| -8.86% | -92.22K |
$16.75 | -$1,544,601.25 | 948.85K |
Aug 13
| |||
Form 4/A
| -8.59% | -97.78K |
$17.49 | -$1,710,230.31 | 1.04M |
Aug 12
| |||
Form 4
| -8.59% | -97.78K |
$14.49 | -$1,416,875.31 | 1.04M |
Aug 12
| |||
Form 4
| -30.51% | -250.00K |
$12.29 | -$3,072,500.00 | 569.43K |
Nov 18
| |||
Form 4
| +107.04% | 793.76K |
$14.00 | $1,449,000.00 | 1.54M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELRX PHARMACEUTICALS INC (ACRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +43.74% | 3.83M |
$5.00 | $6,448,950.00 | 12.59M |
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NORTH AMERICAN SCIENTIFIC INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +793.70% | 40.65M |
$0.25 | $10,000,003.32 | 45.77M |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||